[NCCN Asian consensus statement - can Asian patients with cancer accept treatment modalities from NCCN guidelines ?]

Seiichiro Ozono; Shiro Hinotsu; Mikio Namiki; Hideyuki Akaza

[NCCN Asian consensus statement - can Asian patients with cancer accept treatment modalities from NCCN guidelines ?]

Gan To Kagaku Ryoho. 2014 Jun;41(6):683-6.

[Article in Japanese]

Authors

Seiichiro Ozono¹, Shiro Hinotsu, Mikio Namiki, Hideyuki Akaza

Affiliation

¹ Dept. of Urology, Hamamatsu University, School of Medicine.

PMID: 25129079

Abstract

To spread the National Comprehensive Cancer Network(NCCN)guidelines widely in Asia, committee members from Asian countries have been preparing an Asia Consensus Statement(ACS)along the NCCN guidelines. The ACS for Kidney Cancer guidelines and Prostate Cancer guidelines were issued in 2009 and in 2011, respectively. In addition, second versions of both these guidelines were issued in 2011 and 2013, respectively. In this review, the process and contents of NCCN ACS have been described.

Publication types

English Abstract
Review

MeSH terms

Asia
Clinical Trials as Topic
Consensus
Humans
Kidney Neoplasms / therapy*
Male
Practice Guidelines as Topic*
Prostatic Neoplasms / therapy*